Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodolfo A Estrada

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Annals of Internal Medicine|June 5, 2023
In symptomatic PAH, adding sotatercept to stable background therapy improved 6-min walk distance at 24 wkRodolfo A Estrada
Annals of Internal Medicine|November 6, 2023
In severe, uncontrolled asthma, tezepelumab reduced exacerbations over 1 y regardless of type 2 inflammation levelRodolfo A Estrada, Diego J Maselli
Annals of Internal Medicine|May 6, 2024
SCCM issued recommendations for corticosteroid use in acutely ill adults with sepsis, ARDS, or CAPRodolfo A Estrada, Marcos I Restrepo
Current Opinion in Cardiology|June 25, 2025
The role of imaging in risk assessment for pulmonary arterial hypertensionDivya Verma, Rodolfo A Estrada, Sandeep Sahay
Annals of Internal Medicine|September 4, 2023
In COPD with type 2 inflammation despite inhaled triple therapy, dupilumab safely reduced exacerbationsRodolfo A Estrada, Diego J Maselli, Antonio R Anzueto
Respiratory Medicine|December 5, 2025
Vaccination utilization in patients with pulmonary hypertensionRodolfo A Estrada, Hasan Baher, Liwayway Andrade, et al.
Chest|May 19, 2026
Evolving Concepts in Pulmonary Hypertension: Implementation challenges of the current guidelines and proceedings in the USSandeep Sahay, Rodolfo A Estrada, Megan Griffiths, et al.
Chest|September 12, 2025
Pulmonary Hypertension Associated With Interstitial Lung DiseasesArun Jose, Namita Sood, Jean M Elwing, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Annals of Internal Medicine|June 5, 2023
In symptomatic PAH, adding sotatercept to stable background therapy improved 6-min walk distance at 24 wkRodolfo A Estrada
Annals of Internal Medicine|November 6, 2023
In severe, uncontrolled asthma, tezepelumab reduced exacerbations over 1 y regardless of type 2 inflammation levelRodolfo A Estrada, Diego J Maselli
Annals of Internal Medicine|May 6, 2024
SCCM issued recommendations for corticosteroid use in acutely ill adults with sepsis, ARDS, or CAPRodolfo A Estrada, Marcos I Restrepo
Current Opinion in Cardiology|June 25, 2025
The role of imaging in risk assessment for pulmonary arterial hypertensionDivya Verma, Rodolfo A Estrada, Sandeep Sahay
Annals of Internal Medicine|September 4, 2023
In COPD with type 2 inflammation despite inhaled triple therapy, dupilumab safely reduced exacerbationsRodolfo A Estrada, Diego J Maselli, Antonio R Anzueto
Respiratory Medicine|December 5, 2025
Vaccination utilization in patients with pulmonary hypertensionRodolfo A Estrada, Hasan Baher, Liwayway Andrade, et al.
Chest|May 19, 2026
Evolving Concepts in Pulmonary Hypertension: Implementation challenges of the current guidelines and proceedings in the USSandeep Sahay, Rodolfo A Estrada, Megan Griffiths, et al.
Chest|September 12, 2025
Pulmonary Hypertension Associated With Interstitial Lung DiseasesArun Jose, Namita Sood, Jean M Elwing, et al.
Pageof 1